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Women have been marginalized in the field of cardiac 
research, and studies focusing specifically on women’s 
psychological risk profiles are lacking (Naqvi et al., 2005; 
Wenger, 2003). Coronary heart disease (CHD) in women 
does not present or manifest the same way as in men; symp-
toms of myocardial infarction (MI) are more atypical and 
cardiac events more likely to occur asymptomatically. 
Women are less likely to experience chest pain before an 
MI than men, but significantly more likely to experience 
neck pain, nausea, right-arm pain, dizziness, jaw pain and 
fatigue (Coventry et al., 2011). Furthermore, women typi-
cally experience a heart attack later in life than men and 
hence have more comorbid conditions, and they are also 
less likely to be diagnosed and treated efficiently (Low 
et al., 2010; Möller-Leimkühler, 2007). The European 
guidelines on cardiovascular disease (CVD) prevention in 
clinical practice (Perk et al., 2012) emphasize the inclusion 
of psychosocial factors in CHD risk assessment. However, 
the guidelines offer no gender-specific risk profile in regard 
to anxiety and depression.
Several reviews about the relationship between depression 
and CHD (e.g. Nicholson et al., 2006; Stampfer et al., 2012; 
Van der Kooy et al., 2007; Wulsin and Singal, 2003) and pro-
spective studies (e.g. Gustad et al., 2013; Hawkins et al., 
2013) strongly support that there is an association between 
depression and CHD. Among women, there has been an 
increased prevalence of CHD, and the role of depression as a 
gender-specific factor is still unclear (Naqvi et al., 2005). In a 
Finnish study, symptoms of depression predicted cardiovas-
cular mortality only in women (Haukkala et al., 2009). In 
another study, depressive symptoms were an independent risk 
factor for CHD in women but not in men (Mendes de Leon 
et al., 1998), and depressive symptomatology has been found 
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to be more important in predicting CVD in women than in 
men (Lloyd et al., 1996). In contrary, a French population-
based study found that depressive mood predicted cardiovas-
cular mortality for men only (Lemogne et al., 2012). These 
findings emphasize the importance of both screening for 
depression in general and a focus on the gender-specific role 
of depression in preventive heart interventions.
Women and men represent different populations, and 
therefore, the practice of using men as references should be 
reconsidered (Wenger et al., 2008). Prevalence, incidence, 
and morbidity risk of depressive disorders are higher in 
females than in males (Piccinelli and Wilkinson, 2000). 
Different measures of depression tend to display differenti-
ated gender differences (Salokangas et al., 2002), and in 
some self-report instruments, the differences are reversed, 
that is, men have a higher score on depression (Nortvedt 
et al., 2006; Stordal et al., 2001). At the symptom level, dif-
ferent gender subtypes can be identified (Alexandrino-Silva 
et al., 2013), and this might have implications for under-
standing the depression–CHD relationship. Gender differ-
ences in depression differ from gender differences in CHD, 
suggesting that the association between depression and CHD 
is gender specific (Faravelli et al., 2013; Low et al., 2010).
In medical practice as well as in the research field 
addressing depression and CHD, a variety of operationali-
zations of depression exist (Davidson, 2012; Davidson 
et al., 2005; Stampfer et al., 2012). The relationship between 
affective disorders and CHD seems to vary in strength by 
subtype (Baune et al., 2012). The treatment of depression 
as a unidimensional construct in the research field has left 
several questions unanswered regarding symptom clusters 
(Hawkins et al., 2013) and whether some aspects or sub-
types of depression are more cardiotoxic than others (Doyle 
et al., 2010). Furthermore, different symptomatic profiles 
of depression have been identified in men and women 
(Alexandrino-Silva et al., 2013), so including gender- 
specific analysis is important in understanding the role of 
depression as a risk factor of CHD. It is also possible that 
gender-specific strategies could improve the predictive 
power of a psychological risk profile, but prospective stud-
ies are needed to identify gender-specific risk profiles.
Shaffer et al. (2012) address the importance of research 
on different depression phenotypes and emphasize the role 
of anhedonic depression in the association between depres-
sion and CHD. Recent research on MI has emphasized the 
role of anhedonia (reduced positive affect and loss of inter-
est and pleasure and lack of reactivity to usually pleasura-
ble stimuli) as independently associated with MI (Davidson 
et al., 2010; Denollet et al., 2007). Anhedonia, which refers 
to the reduced or lost capacity to experience pleasure, is a 
feature of major depressive disorder (Di Giannantonio and 
Martinotti, 2012). An emphasis on the distinction between 
depressive syndromes and symptoms and the examination 
of the predictive ability of different operationalization has 
also been requested (Davidson et al., 2005).
Although the study of psychological risk factors of CHD 
has mainly focused on depression, there is a growing 
amount of literature on the link between anxiety and the 
development of CHD (Batelaan et al., 2014; Roest et al., 
2010; Tully et al., 2013). However, the heterogeneity in 
assessment of anxiety imposes major limitations in the 
investigation of the impact of anxiety (Batelaan et al., 
2014). Generalized anxiety disorder (GAD), but not symp-
toms of anxious arousal, has been found to predict mortal-
ity in CHD patients (Tully et al., 2011). In another study, 
symptoms of anxiety predicted mortality in CHD patients 
independent of symptoms of depression (Watkins et al., 
2013). In a study of middle-aged women, a three-item 
measure of symptoms of anxiety predicted fatal cardiovas-
cular incidents (Denollet et al., 2009). In contrast, the study 
by Mykletun et al. (2007) showed that symptoms of anxiety 
were negatively associated with cardiovascular mortality. 
Similarly, others have documented that higher anxiety 
scores are associated with reduced mortality (Meyer et al., 
2010). Furthermore, GAD has been found to predict supe-
rior outcome after an acute coronary syndrome (Parker 
et al., 2011). Other studies have found that symptoms of 
anxiety are not associated with CHD events when control-
ling for depression (Versteeg et al., 2013). Furthermore, 
gender differences in anxiety are highly prevalent, and 
comorbidity between the disorders is higher among women 
(McLean et al., 2011). It is therefore important to include 
measures of anxiety in the search for a gender-specific psy-
chological risk profile.
The European guidelines on CVD prevention (Perk 
et al., 2012) do not specify how depression should be meas-
ured and offer no gender-specific recommendations. This 
study addresses the value of using simple psychological 
screening tools in order to identify men and women at risk 
of having an MI based on their psychological profile.
Although highly comorbid in psychiatric clinical sam-
ples, the comorbidity rates between anxiety and depression 
in CHD patients are substantially lower (Tully and Cosh, 
2013). This is also the conclusion made by Hek et al. 
(2011): Comorbid depression and anxiety are less prevalent 
in older adults, while current anxiety disorders are substan-
tially related to past depression. In this prospective, popula-
tion-based study, a unique linkage between a large health 
survey, clinical assessment, and the national mortality reg-
ister is utilized. This enables the investigation of the roles 
of anhedonic depression, depressive episode, and anxiety 
as gender-specific risk factors of MI.
Method
Study design and participation
The Nord-Trøndelag Health Study (The HUNT Study) is col-
laboration between the HUNT Research Centre (Faculty of 
Medicine, Norwegian University of Science and Technology 
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NTNU), the Nord-Trøndelag County Council, the Central 
Norway Health Authority, and the Norwegian Institute of 
Public Health. HUNT is one of the largest health studies ever 
conducted and is described in Holmen et al. (2003). It is a 
large database of personal and family medical histories col-
lected during three intensive studies over two decades. 
HUNT1 was carried out from 1984 through 1986 to establish 
the health history of 75,000 people. The succeeding HUNT2 
was carried out from 1995 through 1997 and focused on the 
evolution of the health history of 65,049 people. HUNT3 was 
completed in June 2008, and 48,289 people participated (52% 
participation rate). Data were collected by means of question-
naires, interviews, clinical examinations, and collection of 
blood and urine samples.
Of the 65,049 people who participated in HUNT2, those 
with a history of MI or reported current or previous inci-
dents of angina were excluded from the analyses. 
Participation in the HUNT3 study or identification in the 
mortality register was used as the inclusion criteria, result-
ing in 41,248 candidates for this study. A total of 573 partici-
pants in the HUNT3 study (2.5%) reported that they 
currently or prior to the examination had a non-fatal MI. 
According to the mortality register, 249 were classified with 
mortality due to MI, that is, having a fatal MI. The Regional 
Committee for Ethics in Medical Research approved the 
protocols for HUNT2, HUNT3, and for this specific study, 
including the linkage to the mortality register. All partici-
pants in this study gave their written consent.
Measurement of depression and anxiety
The Hospital Anxiety and Depression Scale (HADS; 
Zigmond and Snaith, 1983) includes 14 items with a 4-point 
scale indicating how the respondent has felt over a 2-week 
period prior to measurement. HADS has been found supe-
rior to other depression scales when measuring cardiotoxic 
symptoms, as HADS focuses mainly on anhedonia (Doyle 
et al., 2012). However, HADS does not include somatic 
symptoms, a symptom cluster identified as important in 
relation to CHD (Hawkins et al., 2013).
The HADS anxiety scale contains items that cover wor-
rying, restlessness, and panic attacks. It has been proven to 
have good clinical value and case-finding abilities (Olssøn 
et al., 2005). In the depression subscale, the dominant focus 
is on anhedonia (Mykletun et al., 2001). In this study, a 
Norwegian translation of HADS was used (Mykletun et al., 
2001). A score on HADS-A and HADS-D ≥8 on the respec-
tive scales was used as an indicator of case-level anxiety 
and depression (Bjelland et al., 2002).
Depressive episode
In an extended part of the HUNT2, the participants were 
instructed to indicate whether, during their life, there had 
been periods of two consecutive weeks or more when they 
“felt depressed, sad, and down,” “had appetite problems or 
ate too little,” “felt weak (adynamic) or lacked energy,” 
“really reproached yourself and felt worthless,” or “had 
problems concentrating or had difficulty making decisions.” 
Participants were classified as having experienced a depres-
sive episode if they answered yes to the question, “During 
your life, have there been periods of two consecutive weeks 
or more when you had at least three of the above-mentioned 
problems simultaneously?”
Hypertension, cholesterol, waist–hip ratio
Participants’ systolic blood pressure (SBP) was measured 
by specifically trained nurses using a cuff adjusted for 
arm circumference in HUNT2. SBP was measured three 
times, and a mean was calculated from the second and 
third observations to ensure reliable measurements. Total 
serum cholesterol was measured applying an enzymatic 
colorimetric cholesterol esterase method (Holmen et al., 
2003). Waist and hip circumferences were measured with 
a steel band to the nearest 1.0 cm with the participant 
standing and with the arms hanging relaxed. The waist 
circumference was measured horizontally at the height of 
the umbilicus, and the hip circumference was measured at 
the thickest part of the hip (Holmen et al., 2003). The 
International Diabetes Federation (IDF) has also provided 
recommendations for cut-offs for waist circumference and 
waist–hip ratio. The recommendations are gender, popu-
lation, and geography specific. For Europeans, the recom-
mended cutoff scores are .80 for women and .94 for men 
to identify central obesity (Alberti et al., 2006).
Diabetes and smoking
Smoking was self-reported and operationalized as numbers 
of years of daily smoking. Diabetes was also self-assessed 
by answering yes or no.
End point: fatal and non-fatal MI
The mortality data were obtained from the National Mortality 
Register by combining the mortality database and the HUNT 
data by means of an 11-digit personal identity number. In the 
mortality registry, diagnoses are encoded according to 
International Classification of Diseases, 10th Revision (ICD-
10). MI mortality in this study encompasses ICD-10 codes 
I21-9, unspecified acute MI, and I22-9 subsequent MI with 
unspecified location, with the majority of cases being I21-9. 
Non-fatal MI was indicated by self-report in the HUNT3 
study as a “yes” or “no” response to the question, “Have you 
ever had or do you have myocardial infarction?”
Statistical analysis
Independent-samples t-test and χ2 were conducted to com-
pare the groups on the baseline characteristics at HUNT2. 
Logistic regressions were applied to investigate the effect 
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on MI. The dependent variable was dichotomous (MI/non-
MI). Separate analyses were performed for men and women 
to enable comparison of the risk predictor’s gender-specific 
magnitude. The psychological variables were entered in 
Step 1, whereas the traditional risk factors were entered in 
Step 2 to adjust the model.
Results
In the total sample of 41,248 subjects, 822 of the partici-
pants had a fatal (249) or non-fatal (573) MI. Of those with 
a HADS-D score ≥8 (3621), 59.3 percent (2148) had a 
HADS-A score ≥8, and 5.7 percent (2148) had a history of 
depressive episode. Compared to men, women reported 
higher prevalence of prior depressive episode (6597/22,013 
vs 3060/18,413, χ2 = 982.81 (1), Φ = 16, p < .001). Women 
were overrepresented in the HADS-A ≥8 group as 1907 out 
of 2203 women had a HADS-A score equal or above 8, 
whereas the respective numbers for the men were 2291 out 
of 18,413 (χ2 = 317.71 (1), Φ = .07, p < .001). Men were 
marginally overrepresented in the HADS-D >8 group; 1714 
out of 18,413 men and 1907 out of 22,013 women had a 
HADS-D score ≥8 (χ2 = 5.12 (1), Φ = .01, p < .03. Analysis 
between the outcome variable MI versus non-MI group and 
predictors performed by t-test and χ2 showed significant 
associations and group differences related to all predictors 
except depressive episodes. The prevalence of elevated 
symptoms of anxiety was higher in the non-MI group, 
although this association was significant only for men. 
Prevalence of depression measured by HADS-D was sig-
nificantly different in the MI versus the non-MI group in 
both men and women, whereas depressive episodes were 
not. There was a significant association between HADS-D 
and depressive episode (Φ = .25, p < .001) and a significant 
association between HADS-D and HADS-A (Φ = .39, 
p < .001). HADS-A and depressive episode had a signifi-
cant positive association (χ2 = 4498.32 Φ = .33, p < .001; 
Table 1).
Table 2 shows the results of the logistic regression. In 
the total sample, elevated symptoms of depression (>8) 
were a significant predictor of MI, whereas history of 
depression was not. After adjusting for the traditional risk 
factors (gender, cholesterol, waist–hip ratio, diabetes, 
smoking, and SBP), history of depressive episode emerged 
as a significant predictor along with symptoms of depres-
sion. A high score on anxiety (HADS-A >8) significantly 
reduced the risk of having an MI both in the unadjusted 
and adjusted model. In the separate analysis, history of 
depression was not a significant predictor of MI in the 
female sample. Elevated symptoms of depression increased 
the odds of having an MI, whereas the opposite was the 
case for anxiety. Higher score on HADS-A represented 
reduced risk of having an MI in the male sample, and the 
effect size (odds ratio (OR)) of this predictor was stronger 
compared to the female sample in both the unadjusted and 
adjusted model. History of depressive episode was a sig-
nificant predictor of MI in men, and elevated symptoms of 
depression were a significant predictor only in the unad-
justed model.
Post hoc analyses of risk differences
To investigate whether the gender differences in risk were 
statistically significant, the statistical approach suggested 
by Paternoster et al. (1998) was applied. In this procedure, 
a Z-score is calculated, and according to the results, there 
was a significant difference in risk estimate based on 
HADS-D; Z = 2.96, p = .002. The difference in risk-based 
anxiety (Z = .62) and history of depression (Z = 1.57) did not 
reach statistical significance.
Discussion
Women have been marginalized in the search for psycho-
logical risk factors for CHD, and prospective studies apply-
ing separate analyses for men and women have been 
Table 1. Demographic and baseline risk factors in MI (822) versus non-MI group (40,426) sorted by gender (N = 41,248).
Women (22,013) Men (18,413)
 Non-MI 
(21,771)
MI (242) p ≤ Non-MI 
(17,833/17,759)
MI (580) p ≤ 
Age 43.12 (13.07) 57.87 (9.31) .001 43.61 (12.90) 55.81 (9.44) .001
Systolic blood pressure 129.30 (19.02) 148.31 (23.94) .001 136.93 (16.36) 146.73 (18.17) .001
Total cholesterol 5.69 (1.24) 6.94 (1.20) .001 5.72 (1.14) 6.50 (1.07) .001
Diabetes (n) 251 (1.2%) 13 (5.4%) .001 295 (1.7%) 22 (3.8%) .001
WHR (n) 8001 (37.4%) 148 (61.7%) .001 2702 (15.20%) 167 (28.8%) .001
Smoking N years 9.85 (12.10) 19.37 (16.68) .001 11.55 (13.72) 23.31 (15.57) .001
Depression cutoff ≥8 1855 (8.5%) 52 (21.51%) .001 1645 (9.2%) 69 (11.9%) .03
Anxiety cutoff ≥8 (n) 3826 (17.6%) 43 (17.8%) .94 2244 (12.6%) 47 (8.1%) .001
Depressive episode (n) 6514 (29.9%) 83 (34.3%) .14 2949 (16.5%) 111 (19.1%) .10
ΜΙ: myocardial infarction; WHR: waist–hip ratio.
χ2 and t-test for bivariate association between MI and non-MI group.
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requested (Low et al., 2010; Naqvi et al., 2005; Wenger 
et al., 2008). In this study, different psychological risk pro-
files among men and women were identified and support the 
assumption that the association between depression and 
CHD is gender specific (e.g. Faravelli et al., 2013; Low 
et al., 2010). Depression, especially symptoms of anhedonic 
depression as measured by HADS, seems to be a strong pre-
dictor of MI among women, whereas this specific instru-
ment did not contribute in predicting MI among men after 
controlling for traditional risk factors. Post hoc analysis of 
differences in risk estimate showed that this difference was 
statistically significant. This is consistent with other find-
ings of symptoms of depression being more important in 
predicting CHD in women than men (Lloyd et al., 1996). 
History of depressive episodes was more prevalent in 
women and was a significant risk predictor in men only; 
however, the gender difference in risk was not significant. 
Although HADS-D and depressive episodes were correlated 
(Φ = .25), the strength of the relationship between do not 
suggest that these differences could be attributed to co- 
linearity. It rather supports the view that men and women 
represent different populations when it comes to 
understanding the link between depression and CHD 
(Wenger et al., 2008). The higher prevalence of history of 
depressive episodes in women might be the reason that it 
fails to differentiate those at risk of MI. The results support 
that gender differences in depression are important to incor-
porate in understanding the link between depression and 
CHD. Elevated symptoms of depression (HADS-D ≥8) 
were not more prevalent in women, and this is consistent 
with other studies using HADS (e.g. Nortvedt et al., 2006; 
Stordal et al., 2001). However, the results in this study are 
contrary to comparable samples where other measurements 
of depression have been applied (e.g. Mendes de Leon et al., 
1998) and the general literature on gender differences 
(Piccinelli and Wilkinson, 2000). This suggests that HADS-D 
represents a distinct symptom cluster of depression that 
might be especially cardiotoxic for women. HADS does not 
include somatic symptoms, and HADS-D focuses mainly on 
anhedonia (Mykletun et al., 2001). Although the somatic 
cluster has been identified as the most important symptom 
cluster in predicting CHD (Hawkins et al., 2013), this study 
found that other symptom clusters of depression are relevant 
and that positive affect may be cardioprotective, especially 
for women. Hawkins et al. (2013) identified somatic clusters 
followed by positive affect as the most important symptom 
clusters predictive of CHD, but the analyses were not per-
formed separately for men and women, and the role of spe-
cific symptom clusters as more cardiotoxic can only be 
understood by prospective studies including participants free 
of CHD at baseline. Furthermore, separate data analysis 
should be performed, not only controlling for gender (Low 
et al., 2010). The variable “Depressive episode” includes 
both somatic symptoms and lack of positive affect/depressed 
affect, and it might be that somatic clusters are more impor-
tant for men than for women. A lifetime history of depressive 
episodes was a unique predictor of MI in men and not women 
in the adjusted models.
HADS does not include somatic symptoms, and this 
methodological aspect might be the reason why studies 
using HADS-A (e.g. Versteeg et al., 2013), including this 
study, do not find a positive association between anxiety 
and CHD. However, the study by Parker et al. (2011) using 
diagnostic criteria for GAD did find the same results as in 
this study, that is, anxiety being cardioprotective. Although 
distinctive conditions, the relationship between HADS-A 
and GAD is well documented (Olssøn, et al., 2005)
It is important to differentiate between anxiety and 
depression as a prognostic factor in CHD groups and risk 
factor of CHD in healthy populations. While the prognostic 
studies focus on patients with existing CHD, the etiologic 
approach focuses on psychological factors as risk factors of 
CHD, and these represent two different approaches 
(Nicholson et al., 2006; Stampfer et al., 2012). As sug-
gested by Parker et al. (2011), timing is of great impor-
tance, and both anxiety and depression might have quite 
different roles as etiological factors compared to prognostic 
Table 2. Results of logistic regression.
Variables OR (CI) p < 
Psychological variables (total sample)
 Unadjusted
  HADS-D ≥8 2.42 (1.93–3.02) .001
  HADS-A ≥8 .49 (.38–.63) .001
  Depressive episode 1.00 (.84–1.19) .98
 Adjusted
  HADS-D ≥8 1.41 (1.12–1.78) .003
  HADS-A ≥8 .61 (.50–.79) .001
  Depressive episode 1.29 (1.07–1.55) .008
Psychological variables (women)
 Unadjusted
  HADS-D ≥8 3.68 (2.52–5.37) .001
  HADS-A ≥8 .59 (.40–.89) .011
  Depressive episode 1.02 (.75–1.37) .92
 Adjusted
  HADS-D ≥8 2.31 (1.57–3.40) .001
  HADS-A ≥8 .65 (.43–.98) .038
  Depressive episode 1.05 (.77–1.43) .747
Psychological variables (men)
 Unadjusted
  HADS-D ≥8 1.66 (1.25–2.20) .001
  HADS-A ≥8 .45 (.32–.63) .001
  Depressive episode 1.36 (1.09–1.71) .008
 Adjusted
  HADS-D ≥8 1.11 (.83–1.48) .500
  HADS-A ≥8 .55 (.40–.78) .001
  Depressive episode 1.44 (1.14–1.82) .002
CI: confidence interval; OR: odds ratio; HADS: Hospital Anxiety and 
Depression Scale.
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factors. However, the findings of this study of anxiety as a 
protective factor of MI in healthy subjects are consistent 
with studies of patients with acute coronary syndrome, 
where anxiety predicted superior 5-year outcomes (Parker 
et al., 2011). Men are more reluctant to self-refer to primary 
health care (Jeffries and Grogan, 2012), and this might be 
why the protective effect of anxiety is stronger for the male 
sample in this study. Although females were underrepre-
sented, the review of seven etiological studies of initially 
disease-free individuals points to worry as being associated 
with fatal and non-fatal CHD (Tully et al., 2013). Limited 
knowledge about anxiety and CHD has been attributed to 
the assessment of anxiety, and worry has been found 
to have the strongest impact on the onset of CVD compared 
to panic and phobias (Batelaan et al., 2014). More knowl-
edge about the association between depression and anxiety 
can be achieved through the focus on the differential impact 
of types of anxiety (Batelaan et al., 2014) informed by the 
focus on specific symptom cluster/phenotypes of depres-
sion (Hawkins et al., 2013; Shaffer et al., 2012). A higher 
level of specificity might be a promising approach toward a 
more comprehensive understanding of anxiety as a risk or 
protective factor of CHD in general and MI in particular for 
men and women.
Treatment of depression in CHD patients thus far has 
demonstrated only moderate effects (Baumeister et al., 
2011), especially among women (Low et al., 2010). 
However, treatment of depression before the onset of CHD 
has been found to reduce the risk of CVD (Stewart et al., 
2014). This points to the importance of primary prevention 
and suggests that addressing depression as a risk factor has 
more impact than the treatment of depression as a prognos-
tic factor, and hence interventions should aim at screening 
those at risk. Effective and simple screening for depression 
in identifying CHD risk in non-cardiac patients could 
reduce the number of MI deaths among men and women. 
Screening for depression would have a positive impact 
regardless of its association with CHD as depression repre-
sents a major health problem (Möller-Leimkühler, 2007).
In the research on depression and CHD, depression has 
been treated as a unidimensional cluster, whereas more 
recent studies have demonstrated that particular depressive 
symptoms are stronger predictors (Hawkins et al., 2013), 
and the role of anhedonia has received particular attention 
(Davidson et al., 2010; Denollet et al., 2007; Shaffer et al., 
2012). The implication of anhedonia as a specific cardio-
toxic symptom is that this symptom cluster or depression 
subtype, or intermediary phenotype, should be more care-
fully addressed in the preventive strategies (Shaffer et al., 
2012). It is also possible that the type of treatment has not 
been optimal for women (Low et al., 2010; Naqvi et al., 
2005). In the research on anhedonia in major depression, 
agomelatine has shown promising results (Di Giannantonio 
and Martinotti, 2012). The potential of agomelatine to 
reduce the risk of CHD in patients with an anhedonic 
depression subtype should be explored as a possible new 
intervention in prospective studies applying a gender- 
specific approach.
Efficient ways of identifying women with increased 
CHD risk due to psychological factors is necessary in order 
to develop effective prevention and intervention strategies 
(Low et al., 2010). This study suggests that HADS-D could 
be used to identify risk in women, whereas information 
about lifetime depression/depressive episode is more prom-
ising in identifying risk among men. Both represent simple 
and non-invasive approach that easily could be adopted by 
health personnel. Anxiety as measured by HADS-A is not a 
suitable screening tool in identifying risk, according to the 
results of this study, which is in line with other studies that 
have used HADS to explore the association between anxi-
ety and CHD (Versteeg et al., 2013). Further research 
should address whether symptoms of anxiety might be pro-
tective of MI in a general population.
It has been argued that it is premature to conclude that 
depression in general is an independent causal risk factor 
for CHD (Stampfer et al., 2012). The findings from this 
study support this notion, as it seems that too little is known 
about the specific aspects of depression as a CHD risk fac-
tor in men and women. A general recommendation to screen 
for anxiety and depression (Perk et al., 2012) might have 
little benefit, as specific subtypes of depression differenti-
ate in predictive power, and the role of anxiety is far from 
conclusive. In research on the link between depression and 
CHD, more attention should be given to measurement 
issues and levels of specificity. Gender differences in 
depression are important to incorporate, as well as a focus 
on specific aspects of depression symptom clusters and dif-
ferent anxiety diagnoses. The results of this study suggest 
that it would be useful to develop gender-differentiated 
screening tools for depression in preventive CHD care 
and that the role of anxiety as a risk factor needs to be re-
evaluated or reversed.
Strengths and limitations
This study contributes to the existing literature in the fol-
lowing ways: (1) prospective study of a large community-
based sample free of CHD at baseline; (2) it includes all the 
major risk factors; (3) separate analysis is applied for men 
and women (4); two different measures of depression are 
included as potential screening tools; (5) it includes meas-
ures of anxiety; and (6) it includes both fatal and non-fatal 
MI as end-point measures.
The most obvious limitations in this study are as fol-
lows: (1) the reliance on self-reporting measures for several 
variables, and (2) the measure of depressive episode is 
unspecific, as it does not ask when it occurred or whether 
there have been recurrent episodes. Furthermore, a depres-
sive episode as described here does not imply a valid 
assessment of major depressive episode as diagnosed in the 
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Diagnostic and Statistical Manual of Mental Disorders 
(5th ed.; DSM-V). Although HADS has been found to be a 
reliable screening instrument of psychological stress, the 
factorial structure of HADS has been questioned (Martin 
et al., 2003).
This study indicates that men and women represent dif-
ferent populations in the investigation of psychological risk 
factors in the development of MI and that the association 
between depression, anxiety and CHD is gender specific. 
This study emphasizes the importance of screening for 
depression in women with no CHD at baseline. Symptoms 
of anhedonic depression measured by HADS-D might be a 
gender-specific risk factor of MI in women.
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